Remove tag m-ventures
article thumbnail

The 'giant sucking sound' of digital health consolidation

Healthcare IT News - Telehealth

Recent reports indicate explosive growth in venture capital funding for digital health startups, around $15 billion for the first half of 2021, with no slowdown in sight. However, these deal values may be the norm as we see an increased pace of M & A in digital health. Region Tag: Global Edition. billion deal.

article thumbnail

Allurion: first HealthTech IPO of 2023 via SPAC with Compute Health

Lloyd Price

Additionally, the company has been criticized for its high price tag. Engage with the HealthTech Community The community is a valuable resource for anyone who wants to stay up-to-date on the latest trends in HealthTech M&A. The obesity market is highly competitive and there are a number of other weight loss products on the market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. link] HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Subscribe Today!

article thumbnail

HIStalk Interviews Kevin MacDonald, CEO, Kit Check

HIStalk Interviews

We are venture backed and we’re going to grow and become a bigger company, but we’ve got a lot of growing to do in the mean time. Honestly, knowing now how bad the hospital sales cycle is, I’m not sure that we would have started the business. With the venture rounds, our investors have been super supportive.

Nursing 48
article thumbnail

Three More Signposts on the Road to Retail Health – Weight Loss Drugs, OTC Birth Control and Fashion-Meets-the-Flu

Health Populi

Dr. Eric Topol wrote about the category of GLP-1 drugs as “the new obesity breakthrough,” and added, “I’m not using the term ‘breakthrough’ lightly.” Thus, as the tag asserts here, the line was conceived in the context of the Art and Science of feeling better.